HAVN Life Sciences Inc. (HAVLF)
- Previous Close
0.0000 - Open
0.0100 - Bid 0.0100 x --
- Ask 0.1082 x --
- Day's Range
0.0100 - 0.0100 - 52 Week Range
0.0001 - 0.0360 - Volume
22,105 - Avg. Volume
61 - Market Cap (intraday)
326,446 - Beta (5Y Monthly) -0.62
- PE Ratio (TTM)
-- - EPS (TTM)
-4.3700 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is based in Port Moody, Canada.
www.havnlife.comRecent News: HAVLF
View MorePerformance Overview: HAVLF
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HAVLF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HAVLF
View MoreValuation Measures
Market Cap
14.74k
Enterprise Value
23.19k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.01
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-30.27%
Return on Equity (ttm)
-234.52%
Revenue (ttm)
586.98k
Net Income Avi to Common (ttm)
-15.71M
Diluted EPS (ttm)
-4.3700
Balance Sheet and Cash Flow
Total Cash (mrq)
13.99k
Total Debt/Equity (mrq)
3.13%
Levered Free Cash Flow (ttm)
-708.92k